Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the anabolic effects of Genotropin (somatropin) will
improve the height and weight of children with inflammatory based chronic illness who have
failed to grow despite receiving adequate nutrition. The investigators will test the
hypothesis by treating 32 chronically ill children (16 JRA and 16 Crohn's) with growth
hormone (GH) for 12 months and comparing them to baseline.